G1 Therapeutics Inc
NASDAQ:GTHX

Watchlist Manager
G1 Therapeutics Inc Logo
G1 Therapeutics Inc
NASDAQ:GTHX
Watchlist
Price: 7.15 USD Market Closed
Market Cap: $377.2m

Profitability Summary

G1 Therapeutics Inc's profitability score is 29/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

29/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

29/100
Profitability
Score
29/100
Profitability
Score

Margins

Earnings Waterfall
G1 Therapeutics Inc

Margins Comparison
G1 Therapeutics Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
G1 Therapeutics Inc
NASDAQ:GTHX
376.8m USD
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
387B USD
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
184.5B USD
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
174.7B USD
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
121.5B USD
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.2B USD
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
87B AUD
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
44B EUR
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
G1 Therapeutics Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
G1 Therapeutics Inc
NASDAQ:GTHX
376.8m USD
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
387B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
184.5B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
174.7B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
121.5B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.2B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
87B AUD
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
44B EUR
Loading...
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
G1 Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate